Article

bizjournals.com on 2022-06-13 17:24

FDA rejects NRx's breakthrough designation bid for experimental Covid-19 therapy; stock price falls

FDA

Related news

FDA rejects AstraZeneca's experimental diabetes therapy bizjournals.com
MBeiGene drug gets 'breakthrough therapy' designation from FDA marketwatch.com
Digital therapy program for fibromyalgia receives FDA breakthrough device designation TechCrunch
FDA Unveils Considerations for Rescinding Breakthrough Therapy Designation jdsupra.com
Celcuity secures FDA 'breakthrough therapy designation' for breast cancer drug Star Tribune
MInjectable PrEP receives ‘breakthrough therapy’ designation from FDA metroweekly.com
Africa , Asia , South America
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”TechCrunch
Hong Kong
MAlnylam Pharma stock rises 1.5% after FDA gives drug 'breakthrough therapy' designation marketwatch.com
FDA outlines rescission of Breakthrough Therapy Designation - Guidance potentially signals closer agency scrutiny of designations that have been granted jdsupra.com
Break On Through to the Other Side, Part 2: FDA Issues Draft Guidance About Breakthrough Therapy Designation Rescission jdsupra.com
Minsk
MediBeacon device earns ‘breakthrough’ designation from FDA bizjournals.com
Shreis Scalene Sciences gets FDA ‘breakthrough’ designation thedailyrecord.com
FDA Talks Regenerative Medicine Advanced Therapy Designation jdsupra.com
United States
FDA Grants Breakthrough Device Designation To VR Mental Illness Treatment Forbes
Spain , Cranz
FDA Grants Breakthrough Device Designation for EndoStim’s GERD Treatment jdsupra.com
Germany , Cranz
FDA Breakthrough Device Designation for Biology-Guided Radiotherapy (“BgRT”) Device jdsupra.com
United States
Louisville-area medical device company gets FDA breakthrough designation bizjournals.com
ShiraTronics receives Breakthrough Device designation from FDA for migraine tech bizjournals.com
Adaptimmune gets FDA designation to accelerate development of cancer therapy bizjournals.com
FDA grants rare pediatric disease designation to RegenxBio gene therapy bizjournals.com